Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + FOLFIRI in Advanced Gastric Cancer (STAGE)
NCT00699881Phase 2Completed
- Sponsor
- Fudan University
- Start
- May 2008
- Primary completion
- Oct 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of KL-140 in gastric cancer (GC), sponsored by Fudan University. Primary endpoint: Time to Progression. Started May 2008; status: completed.
02
Drugs
KL-140
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00699881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699881.